A novel sputum transport solution eliminates cold chain and supports routine tuberculosis testing in Nepal

J Epidemiol Glob Health. 2016 Dec;6(4):257-265. doi: 10.1016/j.jegh.2016.04.002. Epub 2016 Apr 27.

Abstract

This preliminary study evaluated the transport reagent OMNIgene SPUTUM (OMS) in a real-world, resource-limited setting: a zonal hospital and national tuberculosis (TB) reference laboratory, Nepal. The objectives were to: (1) assess the performance of OMS for transporting sputum from peripheral sites without cold chain stabilization; and (2) compare with Nepal's standard of care (SOC) for Mycobacterium tuberculosis smear and culture diagnostics. Sixty sputa were manually split into a SOC sample (airline-couriered to the laboratory, conventional processing) and an OMS sample (OMS added at collection, no cold chain transport or processing). Smear microscopy and solid culture were performed. Transport was 0-8days. Forty-one samples (68%) were smear-positive using both methods. Of the OMS cultures, 37 (62%) were positive, 22 (36%) were negative, and one (2%) was contaminated. Corresponding SOC results were 32 (53%), 21 (35%), and seven (12%). OMS "rescued" six (i.e., missed using SOC) compared with one rescue using SOC. Of smear-positives, six SOC samples produced contaminated cultures whereas only one OMS sample was contaminated. OMS reduced culture contamination from 12% to 2%, and improved TB detection by 9%. The results suggest that OMS could perform well as a no cold chain, long-term transport solution for smear and culture testing. The findings provide a basis for larger feasibility studies.

Keywords: Culture contamination; Long-term sputum transport; OMNIgene SPUTUM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Nepal
  • Refrigeration / methods*
  • Sputum / microbiology*
  • Tuberculosis / diagnosis*